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1.
A project aimed at presenting initial results from the implementation of the System of Health Accounts has been carried by the Health Policy Unit at the OECD and experts from thirteen member countries. The results are presented in the form of a comparative study (OECD Health Working Papers No. 16 ) and a set of OECD Health Technical Papers presenting individual country studies. This volume is the seventh in this series, presenting the Korean SHA-based health accounts.
2.
In response to the pressing need for reliable and comparable statistics on health expenditure and financing, the OECD, in co-operation with experts from OECD member countries, developed the manual, A System of Health Accounts (SHA), releasing the initial 1.0 version in 2000. Since its publication, a wealth of experience has been accumulated in a number of OECD countries during the process of SHA implementation, and several national publications have already been issued. Furthermore, the Communiqué of Health Ministers, issued at the first meeting of OECD Health Ministers held on May [13] [14] 2004 emphasised the implementation of the System of Health Accounts in member countries as a key item in the future OECD work programme on health.
3.
The Secretariat considers as a key task to disseminate the SHA-based health accounts of OECD member countries and their comparative analysis. In the series of Health Technical Papers -that are also available via the internet -the key results are presented on a country-by-country basis, supported by detailed methodological documentation. They -together with the comparative study -will provide a unique source of health expenditure data with interpretation of SHA-based health accounts. In particular, the results describe in a systematic and comparable way that how, and for what purposes, money is spent in the health systems of the participating countries. These papers are also important in a methodological sense: the analysis of data availability and comparability shows where further harmonisation of national classifications with the International Classification for Health Accounts (SHA-ICHA) would be desirable.
4.
Thirteen countries participated in this project: Australia, Canada, Denmark, Germany, Hungary, Japan, Korea, Mexico, the Netherlands, Poland, Spain, Switzerland and Turkey. The next edition of the comparative study to be published in 2006, is expected to include several additional countries. Meanwhile, new country studies will be presented on the OECD SHA web page and in the Health Technical Papers when they become available.
5.
The OECD Secretariat invites readers to comment on the series of Health Technical Papers on SHA-based health accounts and to make suggestions on possible improvements to the contents and presentation for future editions.
AVANT-PROPOS
6.
L'Unité des politiques de santé de l'OCDE et des experts originaires de treize pays Membres ont mené un projet visant à rendre compte des premiers résultats de la mise en oeuvre du Système de comptes de la santé (SCS). Ces résultats se présentent sous la forme d'une étude comparative (document de travail sur la santé n° 16 de l'OCDE) et d'un ensemble de rapports techniques sur la santé contenant des études par pays. Ce volume est le septième de la série, il examine les comptes de la santé fondés sur le SCS en Corée.
7.
Face à la nécessité croissance de disposer de statistiques fiables et comparables sur les dépenses et le financement des systèmes de santé, l'OCDE, en collaboration avec des experts des pays Membres, a élaboré un manuel intitulé Système des comptes de la santé (SCS), dont la version 1.0 a été publiée en 2000. Depuis sa publication, une grande expérience a été accumulée dans plusieurs pays de l'OCDE au cours du processus d'application du SCS, et plusieurs publications nationales sont déjà parues dans ce domaine. En outre, le Communiqué des ministres de la santé, diffusé lors de la première réunion des ministres de la santé de l'OCDE qui s'est tenue les 13 et 14 mai 2004, qualifie l'application du Système des comptes de la santé dans plusieurs pays Membres d'élément clé du futur programme de travail de l'OCDE sur la santé.
8.
Le Secrétariat juge essentiel de diffuser les comptes de la santé fondés sur le SCS des pays Membres de l'OCDE ainsi que leur analyse comparative. Dans la série des rapports techniques sur la santé, également disponibles sur internet, les principaux résultats sont présentés pays par pays et s'accompagnent de documents détaillés sur la méthodologie employée. Ces rapports, conjugués à l'étude comparative, constituent une source unique de données sur les dépenses de santé et fournissent une interprétation des comptes de la santé fondés sur le SCS. Ils décrivent en particulier de manière systématique et comparable la façon dont les dépenses de santé des pays participants s'effectuent ainsi que leur objet. Ces documents sont également importants d'un point de vue méthodologique : l'analyse de la disponibilité et de la comparabilité des données révèle les domaines dans lesquels il serait souhaitable de poursuivre l'harmonisation des systèmes de classification nationaux avec la classification internationale pour les comptes de la santé (ICHA).
9.
Treize pays ont participé à ce projet : l'Allemagne, l'Australie, le Canada, la Corée, le Danemark, l'Espagne, la Hongrie, le Japon, le Mexique, les Pays-Bas, la Pologne, la Suisse et la Turquie. La prochaine version de l'étude comparative, à paraître en 2006, devrait inclure plusieurs pays supplémentaires. Pendant ce temps, de nouvelles études par pays seront présentées sur la page web du SCS de l'OCDE et dans les rapports techniques sur la santé dès qu'elles seront disponibles.
10.
Le Secrétariat de l'OCDE invite les lecteurs à faire part de leurs commentaires sur la série des rapports techniques sur la santé relatifs aux comptes de la santé fondés sur le SCS, ainsi que de leurs suggestions sur la façon dont le contenu et la présentation des prochaines éditions pourraient être améliorés.
INTRODUCTION
11.
Several Korean researchers had previously produced independent estimates of total health expenditure in Korea. However, considerable differences emerged in both the methods and the results, and total health expenditure estimates differed by over 30%. While most estimates were sound within the different frameworks chosen, it was difficult to compare them with OECD estimates for other countries because they included different health expenditure items.
12.
With the new accounts, it is now possible to better compare total health expenditure of Korea with other OECD countries, even though not all OECD countries include the same items of expenditure in their total health expenditure accounts and are currently at different stages of implementation of the SHA manual.
13.
Until 2002, estimates of health expenditure were made and submitted by the KIHASA (Korean Institute for Health and Social Affairs). Data on health expenditure in OECD Health Data 2003 were based on these. In 2003, the Ministry of Health and Welfare newly commissioned Yonsei University to carry out a project of constructing Korean National Health Accounts according to OECD's System of Health Accounts. Both the differences in data on which estimations are based and the differences in some methods of applying the SHA manual resulted in a significant change in the structure as well as in the value of total health expenditure.
Summary data on health expenditure
• Total health expenditure as a share of GDP was 5.8% in 2001. (Korean Central Bank, which officially estimates GDP figure in Korea, has recently published new series of GDP figures for 1995-2003 that substitute the existing ones. When these new figures for GDP as a denominator are used, the THE share in GDP of the year 2001 will be reduced to 5.1%.)
• The share of current health expenditure in total health expenditure was 94.4% and the remaining 5.6% was on capital formation of health care provider institutions.
• Per capita total was KRW 673 430 (920 USD PPP) and per capita public health expenditure was KRW 368 652 (504 USD PPP). In-patient care, 23.7
Prevention and public health, Total heath expenditure by financing source
14.
Public share in total expenditure was 54.7% (government 10.2% and social security 44.6%), and private share in total expenditure was 45.3% (private insurance 2.2%, out-of-pocket 37%, non-profit 0.4% and corporations 5.6%) 1 ( Figure 1 and Table A1 ).
15.
The private share of health care funding is high by the standards of other OECD countries. It is the third highest share after the United States and Mexico, and well above the OECD average. The high private financing share is linked to substantial out-of-pocket payments, which differs from the US system where private financing derives from widespread private health insurance arrangements. Patients have to pay high co-payments towards their treatment charges, moreover they pay the full cost of services not included in the National Health Insurance benefit range.
Current health expenditure by function (mode of production)
16.
Korean health expenditure is not well classified according to function such as curativerehabilitative care, long-term care and ancillary services, and particularly, long-term care facilities are not yet popular in Korea. (Therefore, standard Figure 2 and Table A2 presented in the majority of the country chapters are not available for Korea.)
17.
Korea has an unusual mix of health expenditure by mode of production, compared with other OECD countries ( Figure 3 and Table A3 ). It has the lowest inpatient share of current health expenditure (23.7% in 2001) . Before the abrupt fall in 2001, the inpatient share had been gradually increasing over the last decades. Inpatient, outpatient and drug shares were 30.3%, 38.6% and 22% respectively in 1999. This past increase in inpatient expenditure was caused in part by a rapid increase in the number of hospital beds. 
Current health expenditure by provider
18.
Of the current health expenditure, 30% was spent on hospitals in 2001, 40.2% was on providers of ambulatory health care (24.7% on offices of physicians; 9.5% on offices of dentists; 5.5% on offices of other health practitioners; and 0.5% on outpatient care centres), and 22% was on retail sellers and other providers of medical goods (19.4% on dispensing chemists) ( Figure 4 and Table A4 ).
19.
But it was quite a different picture when the roles between doctors and dispensing chemists were not taken separately before mid-2000. In 1999, of the current health expenditure, 43.2% was spent on hospitals, 25.1% on offices of physicians and 7.4% was on dispensing chemists.
20.
When observed separately, the outpatient expenditure including doctor-sold drug expenditure gradually increased while pharmacy-sold drug expenditure rapidly decreased in the 1990s. These trends indicate that in the years towards the separation reform, a larger share of drugs was dispensed directly by doctors rather than by pharmacists.
Current health expenditure by function and provider (SHA Table 2) 21.
Share of hospitals in provision of inpatient care was 86.4% in 2001 and that by providers of ambulatory health care 13% (SHA Table 2 .2). In Korea, medical facilities with less than 20 beds are classified as so-called "doctors' clinics"(which are named hereafter as "offices of physicians" following the OECD/SHA manual).
22.
The hospitals' share in the provision of outpatient care was 19.1% in 2001 and that of providers of ambulatory health care 76.8% (among them, offices of physicians 49.4%, offices of dentists 22.1%, offices of other health practitioners 4.1%, and outpatient care centres 1.2%); corporations, 3.3%. In Korea, hospitals maintain large outpatient departments from which they admit many of their inpatients. Both doctor's clinics and hospitals compete for ambulatory patients who are free to choose the facility they want, presumably the one they see as being the most convenient or having the best quality.
23.
Of the hospitals' current health expenditure, inpatient care accounts for 68.1%; outpatient care, 27%; and pharmaceutical and other medical non-durables, 4.9% (SHA Table 2 .3).
Current health expenditure by provider and financing agent
Spending structure of the financing agents (SHA Table 3 .3)
24.
Of current health expenditure by general government (HF.1.), 31.1% was spent on hospitals, 36.4% was on providers of ambulatory health care (28.9% on offices of physicians; 3.9% on offices of dentists; 2.9% on offices of other health practitioners; and 0.7% on outpatient care centres), 22.1% was on retail sale and other providers of medical goods (22% on dispensing chemists), 2.5% was on provision and administration of public health programmes, and 7.9% was on general health administration and insurance.
25.
Of current health expenditure by general government (excluding social security) (HF.1.1), 36.8% was spent on hospitals, 16.6% was on providers of ambulatory health care (14% on offices of physicians; 0.8% on offices of dentists; 1.2% on offices of other health practitioners; and 0.6% on outpatient care centres), 12% was on retail sale and other providers of medical goods (11.9% on dispensing chemists), 11.9% was on provision and administration of public health programmes, and 22.7% was on general health administration and insurance.
26.
Of current health expenditure by social security (HF.1.2), 29.9% was spent on hospitals, 40.3% on providers of ambulatory health care (31.8% on offices of physicians; 4.5% on offices of dentists; 3.3% on offices of other health practitioners; and 0.7% on outpatient care centres), 24.1% on retail sale and other providers of medical goods (24.1% on dispensing chemists) and 5% on general health administration and insurance.
27.
Of current health expenditure from private sources (HF.2.), 28.7% was spent on hospitals, 45.1% on providers of ambulatory health care (19.3% on offices of physicians; 16.8% on offices of dentists; 8.7% on offices of other health practitioners and 0.3% on outpatient care centres), 21.9% on retail sale and other providers of medical goods (15.9% on dispensing chemists; and 6% on all other sales of medical goods), and 4.3% on other industries (3.3% on corporations; and 1% on all other secondary producers).
28.
Of current health expenditure from private insurance (HF.2.1.+2.2.), 59.5% was spent on hospitals and 40.5% on providers of ambulatory health care (40.4% on offices of physicians; and 0.1% on offices of other health practitioners).
29.
Of current health expenditure from out-of-pocket payments (HF.2.3.), 28.2% was spent on hospitals, 47.5% on providers of ambulatory health care (18.9% on offices of physicians; 18.6% on offices of dentists; 9.7% on offices of other health practitioners; and 0.3% on outpatient care centres) and 24.2% on retail sale and other providers of medical goods (17.6% on dispensing chemists; and 6.6% on all other sales of medical goods).
How different providers are financed (SHA Table 3 .2) 30.
Of current health expenditure for hospitals' services, 58.5% was financed by general government (HF.1) (11.5% by general government excluding social security (HF.1.1), and 47% by social security), and 41.5% by private sector (4.7% by private insurance; and 36.8% by out-of-pocket payments).
31.
Of current health expenditure for services of ambulatory health care providers, 51.2% was financed by general government (HF.1) (3.9% by general government excluding social security (HF.1.1), and 47.4% by social security), and 48.8% was by the private sector (2.4% by private insurance; and 46.4% by out-of-pocket payments).
Current health expenditure by function and financing agents
Functional structure of spending by financing agents (SHA Table 4 .3)
32.
Of current health expenditure by general government (HF.1.), 89.5% was spent for personal health care services and goods (27.8% for inpatient services; 37% for outpatient services; and 24.7% for pharmaceuticals etc.) and 10.5% was for collective health services (prevention and public health services, 2.5%; and health administration and health insurance, 7.9%).
33.
Of current health expenditure by general government (excluding social security) (HF.1.1), 65.4% was spent on personal health care services and goods (among them, 28.6% for inpatient services; 22.6% for outpatient services; and 14.2% for pharmaceuticals etc.) and 34.6% was for collective health services (11.9% for prevention and public health services; and 22.7% for health administration and health insurance).
34.
Of current health expenditure by social security (HF.1.2), 94.3% was spent on personal health care services and goods (27.6% for inpatient services; 39.9% for outpatient services; and 26.8% for pharmaceuticals etc.), and 5.7% for collective health services (0.7% for prevention and public health services; and 5% for health administration and health insurance).
35.
Of current health expenditure from private sources (HF.2.), 99.9% was spent on personal health care services and goods (18.3% for inpatient services; 49.5% for outpatient services; 26.2% for pharmaceuticals etc.; and 6% for therapeutic appliances).
36.
All of current health expenditure from private insurance (HF.2.1.+2.2.) was spent on personal health care services and goods (94.1% for inpatient services; 5.3% for outpatient services; and 0.6% for pharmaceuticals etc.).
37.
All of current health expenditure from out-of-pocket payments (HF.2.3.) was spent on personal health care services and goods (14.3% for inpatient services; 50.1% for outpatient services; and 29% for pharmaceuticals etc.; and 6.6% for therapeutic appliances).
How the different functions are financed (SHA Table 4 .2) 38.
Of current health expenditure on inpatient services, 66.4% was financed by general government (HF.1) (11.3% by general government excluding social security (HF.1.1), and 55.1% by social security), and 33.6% was by private sector (9.4% by private insurance; 23.7% by out-of-pocket payments; and 0.5% by non-profit institutions).
39.
Of current health expenditure on outpatient services, 49.3% was financed by general government (HF.1) (5% by general government excluding social security (HF.1.1), and 44.4% by social security), and 50.7% by the private sector (0.3% by private insurance; 46.3% by out-of-pocket payments; 0.8% by non-profit institutions; and 3.3% by corporations).
40.
Of current health expenditure on medical goods, 50% was financed by general government (HF.1) (4.8% by general government excluding social security (HF.1.1), and 45.3% by social security), and 50% by the private sector (0.1% by private insurance; 49.9% by out-of-pocket payments).
41.
Of current health expenditure on pharmaceuticals, 55.1% was financed by general government (HF.1) (5.2% by general government excluding social security (HF.1.1), and 49.9% by social security), and 44.9% by the private sector (0.1% by private insurance; 44.8% by out-of-pocket payments).
42.
Of current health expenditure on prevention and public health services, 98.1% was financed by general government (HF.1) (76% by general government excluding social security (HF.1.1), and 22.1% by social security), and 1.9% by the private sector (corporations).
43.
All of current expenditure on health administration and health insurance was financed by general government (HF.1) (47.4% by general government excluding social security (HF.1.1), and 52.6% by social security).
Conclusions
44.
The new estimation of Total Health Expenditure and construction of National Health Accounts by Yonsei University through a new project commissioned by the Ministry of Health and Welfare has added new tables including providers' aspects, which are expected to be a paramount contribution for evidence-based health policy in Korea, as well as for the construction of Korean health account itself.
45.
There have been considerable differences in the scale of total health expenditure between previous KIHASA's work and the new project. In the former case, out-of-pocket expenditure including pharmaceutical expenditure was estimated from both urban and rural household surveys. However, household surveys are performed for general economic purposes, and thus, with very limited survey questions concerning items of health care and with no distinction made for items among health care providers. Another deficiency in the household survey data is that items which are not classified as pharmaceuticals by SHA criteria such as oriental tonic herbs, deer antlers and ginseng for a healthy body are included under the title "drugs" in the "household survey" and cannot be separated. Thus, in our new project, these household survey data were supplemented, in the estimation of out-of-pocket expenditure, by data from the Health and Nutrition Survey, which has been periodically performed through interviews with about 40 000 persons sampled from all over the country. This survey includes quite a lot of items on medical use, such as disease names, health care providers, number of visits, out-of-pocket payments, etc.
46.
New estimations seem to have greater value in that information on the provider side can be newly added. Further work is now under construction for both backward and forward application of the estimation methods that has been built in the course of constructing health accounts for the years of 1998-2001. Questions on health expenditure in the Nation Health and Nutrition Survey is scheduled to be revised for more valuable information on health expenditure. 
47.
As explained in the main text, there are considerable differences in the scale of total health expenditure between the previous work undertaken by KIHASA and the new project. In the former case, out-of-pocket expenditure including pharmaceutical expenditure was estimated from both urban and rural household surveys. However, household surveys are performed for general economic purposes, and thus, with very limited survey questions concerning items of health care and with no distinction made for items according to health care providers. Another deficiency in the household survey data is that items that are not classified as pharmaceuticals by SHA criteria such as oriental tonic herbs, deer antlers and ginseng for a healthy body are included under the title "drugs" of the "household survey" and cannot be separated. In our new project, thus, these household survey data were supplemented in the estimation of out-of-pocket expenditure by data from the Health and Nutrition Survey, which has been periodically performed through interviews with about 40 000 persons sampled from all over the country. This survey includes quite a lot of items on medical use, such as disease names, health care providers, number of visits, paid out-of-pocket payments, etc.
48.
The OECD SHA manual classifies oriental (traditional) medicine clinics as HP.3.3. "Offices of other health practitioners", which comprises establishments of independent health practitioners (other than physicians and dentists). In Korea, however, oriental medical services and herbal medicine play a far greater role than in other countries. Students who wish to enter oriental medicine schools are required to obtain as high a grade in the entrance examination as those who enter western medical schools. Estimates in this chapter followed the manual, and thus, oriental medicine doctor's clinics are classified as HP. 3.3 "Offices of other health practitioners". But it is recommended that they should be classified as HP.3.1 Offices of physician and, if necessary, three-digit item such as HP.3.1.1 and HP. 3.1.2 can be prepared to distinguish the two.
Other methodological issues
49.
Explanation for HP.5 Provision and administration of public health programmes and HP.6 General health administration and insurance in OECD SHA manual are not clear. Factors of both function and provider are mixed. "Provision and administration of public health programmes" or "General health administration and insurance" are not names for providers, but for functions. Table A2 Total health expenditure by function of care
ANNEX 2: TABLES
Note: Four standard tables are to be presented and numbered in the same way in each country chapter. This table cannot be presented due to lack of separation of long-term care (HC.3) and curative-rehabilitative expenditure in the Korean National Health accounts. 
